STAGEZERO LIFE SCIENCES LTD (SZLS.CA) Stock Price & Overview
TSX:SZLS • CA8525403017
Current stock price
The current stock price of SZLS.CA is 0.04 CAD. Today SZLS.CA is down by 0%. In the past month the price decreased by -11.11%. In the past year, price decreased by -55.56%.
SZLS.CA Key Statistics
- Market Cap
- 4.918M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.17
- Dividend Yield
- N/A
SZLS.CA Stock Performance
SZLS.CA Stock Chart
SZLS.CA Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to SZLS.CA. When comparing the yearly performance of all stocks, SZLS.CA is a bad performer in the overall market: 89.68% of all stocks are doing better.
SZLS.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to SZLS.CA. SZLS.CA may be in some trouble as it scores bad on both profitability and health.
SZLS.CA Earnings
SZLS.CA Forecast & Estimates
SZLS.CA Groups
Sector & Classification
SZLS.CA Financial Highlights
Over the last trailing twelve months SZLS.CA reported a non-GAAP Earnings per Share(EPS) of -0.17. The EPS decreased by -140% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2456.86% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
SZLS.CA Ownership
SZLS.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| EPRX | EUPRAXIA PHARMACEUTICALS INC | N/A | 581.941M | ||
| EDT | SPECTRAL MEDICAL INC | N/A | 399.051M | ||
| HBP | HELIX BIOPHARMA CORP | N/A | 148.177M | ||
| COV | COVALON TECHNOLOGIES LTD | 13.52 | 53.859M | ||
| MDNA | MEDICENNA THERAPEUTICS CORP | N/A | 49.218M | ||
| BCT | BRIACELL THERAPEUTICS CORP | N/A | 39.295M | ||
| MBX | MICROBIX BIOSYSTEMS INC | 3.47 | 33.815M | ||
| RVX | RESVERLOGIX CORP | N/A | 33.198M | ||
| MPH | MEDICURE INC | N/A | 14.094M | ||
| HEM | HEMOSTEMIX INC | N/A | 11.867M | ||
| CSCI | COSCIENS BIOPHARMA INC | N/A | 8.713M | ||
| KNE | KANE BIOTECH INC | N/A | 6.365M | ||
| QPT | QUEST PHARMATECH INC | N/A | 5.92M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Toronto Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About SZLS.CA
Company Profile
StageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for detection of diseases and for personalized health management, with a focus on cancer-related indications. The company is headquartered in Richmond Hill, Ontario and currently employs 40 full-time employees. The firm is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.
Company Info
IPO: 1998-10-30
STAGEZERO LIFE SCIENCES LTD
30-70 East Beaver Creek Road
Richmond Hill ONTARIO L4B 3B2 CA
CEO: James R. Howard-Tripp
Employees: 40
Phone: 19052092030
STAGEZERO LIFE SCIENCES LTD / SZLS.CA FAQ
What does STAGEZERO LIFE SCIENCES LTD do?
StageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for detection of diseases and for personalized health management, with a focus on cancer-related indications. The company is headquartered in Richmond Hill, Ontario and currently employs 40 full-time employees. The firm is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.
What is the current price of SZLS stock?
The current stock price of SZLS.CA is 0.04 CAD.
Does SZLS stock pay dividends?
SZLS.CA does not pay a dividend.
How is the ChartMill rating for STAGEZERO LIFE SCIENCES LTD?
SZLS.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What sector and industry does STAGEZERO LIFE SCIENCES LTD belong to?
STAGEZERO LIFE SCIENCES LTD (SZLS.CA) operates in the Health Care sector and the Biotechnology industry.
How is the valuation of STAGEZERO LIFE SCIENCES LTD (SZLS.CA) based on its PE ratio?
STAGEZERO LIFE SCIENCES LTD (SZLS.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.17).
What is the employee count for SZLS stock?
STAGEZERO LIFE SCIENCES LTD (SZLS.CA) currently has 40 employees.